EBGLYSS 125 MG/ML SOL INJ CT 2 SER PREENC VD TRANS X 2ML + 2 CAN APLIC
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1126002050027 -
GGREM
507625020023802 -
Código de barras
7896382709326
O que a fonte publica
- Detentor do registro
- ELI LILLY DO BRASIL LTDA
- Princípios ativos
- LEBRIQUIZUMABE
- Embalagem
- 125 MG/ML SOL INJ CT 2 SER PREENC VD TRANS X 2ML + 2 CAN APLIC
- Regime de dispensação
- Tarja Vermelha
- Tipo de produto
- Biológico
- Classe terapêutica
- D5X - OUTROS PRODUTOS ANTI-INFLAMATÓRIOS NÃO ESTEROIDAIS DERMATOLÓGICOS
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "EBGLYSS 125 MG/ML SOL INJ CT 2 SER PREENC VD TRANS X 2ML + 2 CAN APLIC",
"holder": "ELI LILLY DO BRASIL LTDA",
"stripe": "Tarja Vermelha",
"barcodes": [
"7896382709326"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "507625020023802",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "43.940.618/0001-44",
"priceRegime": "Regulado",
"productName": "EBGLYSS",
"productType": "Biológico",
"hospitalOnly": false,
"presentation": "125 MG/ML SOL INJ CT 2 SER PREENC VD TRANS X 2ML + 2 CAN APLIC",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha",
"factoryPrices": {
"icms-0": "13481.65",
"icms-12": "15320.06",
"icms-17": "16242.95",
"icms-18": "16441.03",
"icms-19": "16644.01",
"icms-20": "16852.06",
"icms-21": "17065.38",
"icms-22": "17284.16",
"icms-23": "17508.63",
"icms-17.5": "16341.39",
"icms-19.5": "16747.39",
"icms-20.5": "16958.06",
"icms-22.5": "17395.68",
"icms-12-alc": "13678.63",
"icms-17-alc": "14502.63",
"icms-18-alc": "14679.49",
"icms-19-alc": "14860.71",
"icms-20-alc": "15046.48",
"icms-21-alc": "15236.95",
"icms-22-alc": "15432.28",
"icms-23-alc": "15632.70",
"withoutTaxes": "12037.19",
"icms-17.5-alc": "14590.53",
"icms-19.5-alc": "14953.02",
"icms-20.5-alc": "15141.11",
"icms-22.5-alc": "15531.84"
},
"pisCofinsList": "Negativa",
"substanceText": "LEBRIQUIZUMABE",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "18085.15",
"icms-12": "20551.32",
"icms-17": "21789.34",
"icms-18": "22055.06",
"icms-19": "22327.35",
"icms-20": "22606.44",
"icms-21": "22892.60",
"icms-22": "23186.09",
"icms-23": "23487.20",
"icms-17.5": "21921.39",
"icms-19.5": "22466.03",
"icms-20.5": "22748.63",
"icms-22.5": "23335.69",
"icms-12-alc": "18909.90",
"icms-17-alc": "20049.04",
"icms-18-alc": "20293.53",
"icms-19-alc": "20544.06",
"icms-20-alc": "20800.88",
"icms-21-alc": "21064.19",
"icms-22-alc": "21334.22",
"icms-23-alc": "21611.29",
"withoutTaxes": "16640.70",
"icms-17.5-alc": "20170.55",
"icms-19.5-alc": "20671.67",
"icms-20.5-alc": "20931.70",
"icms-22.5-alc": "21471.86"
},
"invalidBarcodes": [],
"activeSubstances": [
"LEBRIQUIZUMABE"
],
"therapeuticClass": "D5X - OUTROS PRODUTOS ANTI-INFLAMATÓRIOS NÃO ESTEROIDAIS DERMATOLÓGICOS",
"commercialisation": {
"year": 2025,
"marketed": false
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1126002050027",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "D5X",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:507625020023802"